Gritstone Oncology Announces the Addition of Jean-Charles Soria, M.D., Ph.D., to its Scientific Advisory Board

NEXT STORY
Global Female Technology (Femtech) Market: Analysis and Forecast, 2019-2030
PREV STORY
Priority Health Selects The Inovalon ONE® Platform
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

VBL Therapeutics to Present Data on New Investigator-Sponsored Phase 2 Trial of VB-111 in Recurrent Glioblastoma at the 2019 Society for Neuro-Oncology Annual Meeting

author_avatar
NASDAQ Market News

Tiziana Life Sciences plc files scheme of arrangement to effect a corporate reorganisation and, if approved, the delisting of its ordinary shares in London and the direct listing of common shares in the new parent company of the Tiziana group on NASDAQ

author_avatar
NASDAQ Market News

Jounce Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results

- Remain on track to announce preliminary efficacy data for the Phase 1/2 ICONIC ...

author_avatar
NASDAQ Market News